top of page
Search
2nd Symposium on Combating Emerging Infectious Diseases
On 16 Dec 2022, a successful collaboration between our organization and the Department of Microbiology at the University of Hong Kong led...
CVVT
Dec 16, 2022
Intranasal Covid19 vaccine developed by our team approved for emergency use in the Mainland
An intranasal Covid19 vaccine developed by researchers at CVVT and the University of Hong Kong (HKU) in collaboration with Xiamen...
CVVT
Dec 5, 2022
Visit By Alibaba Entrepreneurs Fund
This was an exciting day for our center. We had the honor of welcoming executive and investment representatives from the Alibaba...
CVVT
Nov 16, 2022
bottom of page